(Q42905760)

English

Miracle pills for weight loss: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed for naltrexone-bupropion combination?

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

0 references

Miracle pills for weight loss: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed for naltrexone-bupropion combination? (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

1462-1465

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Multicenter, placebo-controlled trial of lorcaserin for weight management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Compelling or irrelevant? Using number needed to treat can help decide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02501.X

21 January 2018

Identifiers

10.1111/J.1742-1241.2010.02501.X

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

release_6r42n4paabdjvbgeqrrqo65bse

1 reference

https://api.fatcat.wiki/v0/release/6r42n4paabdjvbgeqrrqo65bse

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42905760&oldid=1843789921"